Gliclazide

A sulfonylurea antihyperglycemic agent.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

Gliclazide is a drug used for treatment of hyperglycaemia in non-insulin-dependent diabetes mellitus. It acts via insulin release stimulation in β cells in pancreas (DrugBank).

Gliclazide on PubChem
Gliclazide on Wikipedia


 

Structure image - Gliclazide

CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2


Supporting references

Link Tested on Impact factor Notes Publication date
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine
Envelope protein Small molecule In vitro
In vitro ion channel assay 2.99

Blocks the SARS-CoV-2 E protein ion channel in vitro.

Jun/20/2020